Cupps Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-3,751
| Closed | -$471K | – | 220 |
|
|
2015
Q4 | $471K | Buy |
+3,751
| New | +$471K | 0.07% | 129 |
|
|
2015
Q3 | – | Sell |
-3,410
| Closed | -$421K | – | 208 |
|
|
2015
Q2 | $421K | Sell |
3,410
-255
| -7% | -$31.5K | 0.04% | 137 |
|
|
2015
Q1 | $432K | Sell |
3,665
-23,775
| -87% | -$2.8M | 0.04% | 152 |
|
|
2014
Q4 | $3.26M | Sell |
27,440
-11,708
| -30% | -$1.39M | 0.29% | 92 |
|
|
2014
Q3 | $4.4M | Buy |
39,148
+20,643
| +112% | +$2.32M | 0.41% | 90 |
|
|
2014
Q2 | $1.75M | Sell |
18,505
-18,250
| -50% | -$1.73M | 0.14% | 131 |
|
|
2014
Q1 | $2.6M | Buy |
36,755
+31,204
| +562% | +$2.21M | 0.2% | 118 |
|
|
2013
Q4 | $412K | Buy |
+5,551
| New | +$412K | 0.03% | 130 |
|
|
2013
Q3 | – | Sell |
-11,053
| Closed | -$884K | – | 213 |
|
|
2013
Q2 | $884K | Buy |
+11,053
| New | +$884K | 0.07% | 117 |
|